Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
2.
3.

L-Carnitine dissimilation in the gastrointestinal tract of the rat.

Rebouche CJ, Mack DL, Edmonson PF.

Biochemistry. 1984 Dec 18;23(26):6422-6.

PMID:
6529558
4.

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.

Kuka J, Liepinsh E, Makrecka-Kuka M, Liepins J, Cirule H, Gustina D, Loza E, Zharkova-Malkova O, Grinberga S, Pugovics O, Dambrova M.

Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7.

PMID:
25301199
5.

Butyrobetaine is equal to L-carnitine in elevating L-carnitine levels in rats.

Sandor A.

Biochim Biophys Acta. 1991 May 8;1083(2):135-8.

PMID:
2036448
6.
7.

Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.

Schoenig GP, Hartnagel RE Jr, Osimitz TG, Llanso S.

Drug Metab Dispos. 1996 Feb;24(2):156-63.

PMID:
8742226
8.

Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.

Rebouche CJ.

Ann N Y Acad Sci. 2004 Nov;1033:30-41. Review.

PMID:
15591001
9.
10.

Mammalian-microbial cometabolism of L-carnitine in the context of atherosclerosis.

Claus SP.

Cell Metab. 2014 Nov 4;20(5):699-700. doi: 10.1016/j.cmet.2014.10.014. Epub 2014 Nov 4.

11.

Disposition and metabolite kinetics of oral L-carnitine in humans.

Bain MA, Milne RW, Evans AM.

J Clin Pharmacol. 2006 Oct;46(10):1163-70.

PMID:
16988205
13.
14.

Utilization of dietary precursors for carnitine synthesis in human adults.

Rebouche CJ, Bosch EP, Chenard CA, Schabold KJ, Nelson SE.

J Nutr. 1989 Dec;119(12):1907-13.

PMID:
2516120
16.

γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.

Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, Tang WH, DiDonato JA, Lusis AJ, Hazen SL.

Cell Metab. 2014 Nov 4;20(5):799-812. doi: 10.1016/j.cmet.2014.10.006. Epub 2014 Nov 4.

17.

Catabolic pathways for high-dosed L(-)- or D(+)-carnitine in germ-free rats?

Seim H, Schulze J, Strack E.

Biol Chem Hoppe Seyler. 1985 Nov;366(11):1017-21.

PMID:
4074494
18.

Oral L-carnitine: metabolite formation and hemodialysis.

Bain MA, Faull R, Milne RW, Evans AM.

Curr Drug Metab. 2006 Oct;7(7):811-6.

PMID:
17073580
20.

Supplemental Content

Support Center